A Phase I Study of TS-142 in Healthy Participants (Single Doses)

A Phase I Study of TS-142 in Non-Elderly Healthy Participants (Single Doses) (A Single Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TS-142 in Non-Elderly Participants)

The purpose of this study is to investigate the safety and pharmacokinetics of single dosing of TS-142 to healthy Japanese non-elderly participants in fasting and after meal condition.

Inclusion Criteria:

• Body mass index (BMI) ≥18.5 and <25.0 kg/m^2 at screening inspection

Exclusion Criteria:

• History of clinically relevant disease of some organ systems that may be considerd inappropriately for this study
• History of drug and food allergy